Attention Deficit Hyperactive Disorder(ADHD). Attention-deficit hyperactivity disorder, predominantly hyperactive type
Conditions
Interventions
Intervention 1: Intervention group: The patients included in the study during a period of 8 weeks are divided into three groups, the first group of Etentaline syrup (the first week 0.25 ml once a day,
Sponsors
Sanandaj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Years to 6 Years
Inclusion criteria
Inclusion criteria: The age range of these children is 3 to 6 years According to the DSM-5 diagnostic criterion, the child and adolescent psychiatrist should diagnose ADHD in children.
Exclusion criteria
Exclusion criteria: The presence of a serious physical illness, such as a seizure, based on parental history and clinical suspicion Existence of comorbid psychiatric disorder other than confrontational disobedience disorder Mental retardation based on clinical suspicion Taking medications for Attention Deficit Hyperactivity Disorder in the last month History of allergy to ethenalin and Ahura hyperactive
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Parent’s ADHD Rating scale Number. Timepoint: At the beginning of the study (baseline), 2 weeks, 4 weeks and 8 weeks after the study. Method of measurement: Parent’s ADHD Rating scale.;Clinical Global Impressions Number. Timepoint: At the beginning of the study (baseline), 2 weeks, 4 weeks and 8 weeks after the study. Method of measurement: Clinical Global Impressions. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSoliman Mohammadzadeh
Sanandaj University of Medical Sciences
Outcome results
None listed